» Articles » PMID: 25473089

Dodecyl Maltopyranoside Enabled Purification of Active Human GABA Type A Receptors for Deep and Direct Proteomic Sequencing

Overview
Date 2014 Dec 5
PMID 25473089
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The challenge in high-quality membrane proteomics is all about sample preparation prior to HPLC, and the cell-to-protein step poses a long-standing bottleneck. Traditional protein extraction methods apply ionic or poly-disperse detergents, harsh denaturation, and repeated protein/peptide precipitation/resolubilization afterward, but suffer low yield, low reproducibility, and low sequence coverage. Contrary to attempts to subdue, we resolved this challenge by providing proteins nature-and-activity-promoting conditions throughout preparation. Using 285-kDa hetero-pentameric human GABA type A receptor overexpressed in HEK293 as a model, we describe a n-dodecyl-β-d-maltopyranoside/cholesteryl hemisuccinate (DDM/CHS)-based affinity purification method, that produced active receptors, supported protease activity, and allowed high performance with both in-gel and direct gel-free proteomic analyses-without detergent removal. Unlike conventional belief that detergents must be removed before HPLC MS, the high-purity low-dose nonionic detergent DDM did not interfere with peptides, and obviated removal or desalting. Sonication or dropwise addition of detergent robustly solubilized over 90% of membrane pellets. The purification conditions were comparable to those applied in successful crystallizations of most membrane proteins. These results enabled streamlined proteomics of human synaptic membrane proteins, and more importantly, allowed directly coupling proteomics with crystallography to characterize both static and dynamic structures of membrane proteins in crystallization pipelines.

Citing Articles

Expression of Recombinant Insulin-Like Growth Factor-Binding Protein-3 Receptor in Mammalian Cell Line and Prokaryotic () Expression Systems.

Naseri N, Mirian M, Mofid M Adv Biomed Res. 2022; 11:19.

PMID: 35386539 PMC: 8977618. DOI: 10.4103/abr.abr_197_20.


Identification of binding sites contributing to volatile anesthetic effects on GABA type A receptors.

Woll K, Zhou X, Bhanu N, Garcia B, Covarrubias M, Miller K FASEB J. 2018; 32(8):4172-4189.

PMID: 29505303 PMC: 6044061. DOI: 10.1096/fj.201701347R.


Comparison of αβδ and αβγ GABA receptors: Allosteric modulation and identification of subunit arrangement by site-selective general anesthetics.

Feng H, Forman S Pharmacol Res. 2018; 133:289-300.

PMID: 29294355 PMC: 6026480. DOI: 10.1016/j.phrs.2017.12.031.


Lack of specificity of antibodies raised against CLN3, the lysosomal/endosomal transmembrane protein mutated in juvenile Batten disease.

Nelson T, Pearce D, Kovacs A Biosci Rep. 2017; 37(6).

PMID: 29089465 PMC: 5700270. DOI: 10.1042/BSR20171229.


Mapping General Anesthetic Sites in Heteromeric γ-Aminobutyric Acid Type A Receptors Reveals a Potential For Targeting Receptor Subtypes.

Forman S, Miller K Anesth Analg. 2016; 123(5):1263-1273.

PMID: 27167687 PMC: 5073028. DOI: 10.1213/ANE.0000000000001368.


References
1.
Baulac S, Huberfeld G, Gourfinkel-An I, Mitropoulou G, Beranger A, Prudhomme J . First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet. 2001; 28(1):46-8. DOI: 10.1038/ng0501-46. View

2.
WALLACE R, Marini C, Petrou S, Harkin L, Bowser D, Panchal R . Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet. 2001; 28(1):49-52. DOI: 10.1038/ng0501-49. View

3.
Garavito R, Ferguson-Miller S . Detergents as tools in membrane biochemistry. J Biol Chem. 2001; 276(35):32403-6. DOI: 10.1074/jbc.R100031200. View

4.
Norton W, Abe T, Poduslo S, DeVries G . The lipid composition of isolated brain cells and axons. J Neurosci Res. 1975; 1(1):57-75. DOI: 10.1002/jnr.490010106. View

5.
Marini C, Harkin L, Wallace R, Mulley J, Scheffer I, Berkovic S . Childhood absence epilepsy and febrile seizures: a family with a GABA(A) receptor mutation. Brain. 2002; 126(Pt 1):230-40. DOI: 10.1093/brain/awg018. View